Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab

Michael T Meister; Sandra Voss; Dirk Schwabe

doi:10.1002/pbc.25884

Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab

Michael T Meister, Sandra Voss, Dirk Schwabe

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Originele taal-2	Engels
Pagina's (van-tot)	947
Aantal pagina's	1
Tijdschrift	Pediatric blood & cancer
Volume	63
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1002/pbc.25884
Status	Gepubliceerd - mei 2016
Extern gepubliceerd	Ja

Toegang tot document

10.1002/pbc.25884

Citeer dit

@article{df596808adac4f84998d5b1b876476a8,

title = "Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab",

keywords = "Antineoplastic Combined Chemotherapy Protocols/administration \& dosage, Ataxia Telangiectasia/drug therapy, Epstein-Barr Virus Infections/drug therapy, Herpesvirus 4, Human, Hodgkin Disease/drug therapy, Humans, Immunoconjugates/administration \& dosage, Male, Rituximab/administration \& dosage",

author = "Meister, \{Michael T\} and Sandra Voss and Dirk Schwabe",

year = "2016",

month = may,

doi = "10.1002/pbc.25884",

language = "English",

volume = "63",

pages = "947",

journal = "Pediatric blood \& cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Reply to Comment on

T2 - Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab

AU - Meister, Michael T

AU - Voss, Sandra

AU - Schwabe, Dirk

PY - 2016/5

Y1 - 2016/5

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Ataxia Telangiectasia/drug therapy

KW - Epstein-Barr Virus Infections/drug therapy

KW - Herpesvirus 4, Human

KW - Hodgkin Disease/drug therapy

KW - Humans

KW - Immunoconjugates/administration & dosage

KW - Male

KW - Rituximab/administration & dosage

UR - https://www.scopus.com/pages/publications/84961231259

U2 - 10.1002/pbc.25884

DO - 10.1002/pbc.25884

M3 - Article

C2 - 26739927

SN - 1545-5009

VL - 63

SP - 947

JO - Pediatric blood & cancer

JF - Pediatric blood & cancer

IS - 5

ER -